GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax Inc (OTCPK:AFFY) » Definitions » E10

Affymax (Affymax) E10 : $0.00 (As of Jun. 2014)


View and export this data going back to 2006. Start your Free Trial

What is Affymax E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Affymax's adjusted earnings per share data for the three months ended in Jun. 2014 was $0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Jun. 2014.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-26), Affymax's current stock price is $0.0007. Affymax's E10 for the quarter that ended in Jun. 2014 was $0.00. Affymax's Shiller PE Ratio of today is .


Affymax E10 Historical Data

The historical data trend for Affymax's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax E10 Chart

Affymax Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -50.92 -38.74 -26.40

Affymax Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -26.40 - -

Competitive Comparison of Affymax's E10

For the Biotechnology subindustry, Affymax's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affymax's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Affymax's Shiller PE Ratio falls into.



Affymax E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Affymax's adjusted earnings per share data for the three months ended in Jun. 2014 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2014 (Change)*Current CPI (Jun. 2014)
=0.19/100.5595*100.5595
=0.190

Current CPI (Jun. 2014) = 100.5595.

Affymax Quarterly Data

per share eps CPI Adj_EPS
200409 -17.600 80.121 -22.090
200412 -17.600 80.290 -22.043
200503 -23.057 81.555 -28.430
200506 -23.057 82.062 -28.254
200509 -23.057 83.876 -27.643
200512 -32.480 83.032 -39.336
200603 -20.340 84.298 -24.264
200606 -23.490 85.606 -27.593
200609 -4.760 85.606 -5.591
200612 -0.524 85.142 -0.619
200703 -0.480 86.640 -0.557
200706 -0.620 87.906 -0.709
200709 -0.850 87.964 -0.972
200712 -0.920 88.616 -1.044
200803 -1.030 90.090 -1.150
200806 -1.240 92.320 -1.351
200809 -1.720 92.307 -1.874
200812 -1.680 88.697 -1.905
200903 -1.320 89.744 -1.479
200906 -1.170 91.003 -1.293
200909 -0.970 91.120 -1.070
200912 -0.630 91.111 -0.695
201003 -0.330 91.821 -0.361
201006 0.700 91.962 0.765
201009 -0.490 92.162 -0.535
201012 -0.460 92.474 -0.500
201103 -0.360 94.283 -0.384
201106 -0.350 95.235 -0.370
201109 -0.280 95.727 -0.294
201112 -0.860 95.213 -0.908
201203 0.870 96.783 0.904
201206 -0.890 96.819 -0.924
201209 -0.680 97.633 -0.700
201212 -1.850 96.871 -1.920
201303 -0.720 98.209 -0.737
201306 0.410 98.518 0.418
201309 -0.050 98.790 -0.051
201312 -0.040 98.326 -0.041
201403 -0.040 99.695 -0.040
201406 0.190 100.560 0.190

Add all the adjusted EPS together and divide 10 will get our e10.


Affymax  (OTCPK:AFFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Affymax E10 Related Terms

Thank you for viewing the detailed overview of Affymax's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Affymax (Affymax) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.
Executives
John Peter Walker director 126 ISABELLA AVE, ATHERTON CA 94027
John A Orwin director C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Mark G Thompson officer: Chief Financial Officer 8383 WILSHIRE BLVD BEVERLY HILLS CA 90211
Jeffrey H Knapp officer: Chief Commercial Officer 4001 MIRANDA AVE. PALO ALTO CA 94304
Herb Cross officer: Chief Financial Officer 3061 ZANKER RD, SAN JOSE CA 95134
Anne-marie Duliege officer: Chief Medical Officer 4001 MIRANDA AVENUE, PALO ALTO CA 94304
Kathleen Laporte director
Karin L Walker officer: VP, Finance & CAO C/O PROTHENA CORPORATION PLC, 650 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Heek Christi Van director 4001 MIRANDA AVENUE, PALO ALTO CA 94304
Daniel K Spiegelman director MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003
Hollings Renton director
Keith R Leonard director ARYX THERAPEUTICS,INC., 6300 DUMBARTON CIRCLE, FREMONT CA 94555
Ted W Love director C/O GLOBAL BLOOD THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO CA 94080
Paul B Cleveland officer: EVP, Corp. Development and CFO C/O AFFYMAX, INC., 4001 MIRANDA AVE., PALO ALTO CA 94304
Arlene Morris director, officer: CEO C/O AFFYMAX, INC., 4001 MIRANDA AVE., PALO ALTO CA 94304

Affymax (Affymax) Headlines

From GuruFocus

AFFYMAX, INC. (AFFY) President and CEO Arlene Morris sells 101,100 Shares

By GuruFocus Research GuruFocus Editor 09-30-2009

AFFYMAX, INC. (AFFY) CEO Arlene Morris sells 180,410 Shares

By GuruFocus Research GuruFocus Editor 05-13-2010

AFFYMAX, INC. (AFFY) CEO Arlene Morris sells 52,896 Shares

By GuruFocus Research GuruFocus Editor 05-19-2010